Reliable and rapid antimicrobial resistance identification for appropriate therapy
Join us on Thursday, December 10, to discover how to rapidly diagnose antimicrobial resistance for appropriate therapy
Join us on Thursday, December 10, to discover how to rapidly diagnose antimicrobial resistance for appropriate therapy
Watch this on-demand webinar to learn how COVID immune responses can be assessed using a novel microfluidic in-solution immunoassay platform
Trends in biomarker discovery methods and novel techniques advancing research, clinical diagnostics and therapeutic development
Watch this on-demand webinar to discover how gel-encapsulated microdroplets can be analyzed by high-throughput droplet sorting for genomic, proteomic, and metabolomic profiling
Dr. Chris Mason shares his extensive research into the SARS-CoV-2 immune response and the similarities experienced by astronauts landing back on Earth
Researchers recommend that targeted nutrition should be urgently explored as a counter-measure to mitochondrial damage
Designed to enrich pathologists' skills in biomarker interpretation and scoring techniques
The assay is developed for use in detection, characterisation, and monitoring of the SARS-CoV-2 virus
From sample prep to downstream analysis, discover the products making a difference for other scientists in your field
Learn how microbiological quality control tests at Coca-Cola ensure consumer safety
All the talks and resources exploring the latest research and methods in the field are now available free and on demand - but for a limited time only
Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection
Prof. Silke Christiansen describes how she explores the mechanical properties of bone to help better treat osteoporosis and highlights the technological advances enabling new insights
Phase 3 interim analysis including 131 Covid-19 cases indicates that the vaccine is 70.4% effective when combining data from two dosing regimens
Two different dosing regimens demonstrated efficacy with one showing a better profile
Sangmi Han discusses how cell counters have become an integral part of Macrogen’s single-cell RNA sequencing workflow
Join us on Wednesday, December 2, to learn how the BioAccord LC-MS System delivers robust UPLC separations performance and accurate mass data for a diverse range of modified oligonucleotides